This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Va...
Human medicines European public assessment report (EPAR): Daptomycin Hospira, da...
Human medicines European public assessment report (EPAR): Ulunar Breezhaler, ind...
Minutes - HMA-EMA joint Big Data Steering Group teleconference - 11 December 2024
International Coalition of Medicines Regulatory Authorities (ICMRA)
Contact details of national competent authorities for requests of translation ex...
Fifth EMA/HMA Big Data Stakeholder Forum, Online, European Medicines Agency, Ams...
Human medicines European public assessment report (EPAR): Mekinist, trametinib, ...
EU Implementation Guide (IG) on veterinary medicines product data in the Union P...
European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare P...
Human medicines European public assessment report (EPAR): CellCept, mycophenolat...
Human medicines European public assessment report (EPAR): Trydonis, beclometason...
Human medicines European public assessment report (EPAR): Trimbow, beclometasone...
Human medicines European public assessment report (EPAR): Evenity, romosozumab, ...
Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, ...